|Assessment process complete
|Lidocaine 5% plasters
|For the symptomatic relief of neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia, PHN).
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Full Pharmacoeconomic Assessment Recommended.
|Full pharmacoeconomic assessment commissioned by HSE
|NCPE assessment completed
|NCPE assessment outcome
|Reimbursement Not Recommended
The NCPE concludes that the cost effectiveness of the 5% lidocaine plaster has not been demonstrated.